Abstract Three closely related human SEC14p-like proteins (hTAP1, hTAP2, hTAP3, or SEC14L2, SEC14L3, SEC14L4, respectively) have been described that are related to the Saccharomyces cerevisiae SEC14 protein.
Introduction
Three human tocopherol associated proteins (hTAP1, hTAP2, hTAP3, also named SEC14L2, SEC14L3, SEC14L4, respectively) have been described [1, 2] . Although the three genes are closely related at the nucleic acid and protein sequence (reviewed in [3] [4] [5] ), they are expressed at different levels in human tissue and exhibit cell specificity within the same organ [1, 6, 7] . Among the tested human tissues, high expression of hTAP3 was seen in the epithelial duct cells of several glands [7] . To date no diseases directly linked to the hTAP genes have been described. However, mutations in related proteins such as PITP, a-TTP, CRALBP or ATCAY can lead to hereditary disease, clearly underlying the importance of a correct protein-mediated distribution of hydrophobic molecules [8] [9] [10] [11] [12] .
The hTAP proteins can recognize phospholipids, squalene, and specific tocopherol analogues and derivatives, suggesting that they may contribute to the cellular uptake, intracellular distribution and secretion of several ligands [1, [13] [14] [15] . In addition, the hTAP proteins interact with phosphatidylinositol kinase (PI3K) and possibly modulate the PI3K/PKB signal transduction pathway [1] . This finding was confirmed in prostate tumours in which overexpression of TAP1 increased tocopherol uptake and acted as tumour suppressor by modulating PI3K/PKB activity and cell proliferation [16, 17] . Tocopherols and phosphatidylinositol compete for binding to hTAPs, suggesting that tocopherols may modulate phospholipid-dependent signalling pathways [1, 14] . Since the hTAP proteins show a selective binding capacity toward the different natural tocopherols and tocotrienols [15] , it can be assumed that these proteins confer specificity by mediating their recognition and selective transport to enzymes, transcription factors, nuclear receptors, organelles such as mitochondria, or specific plasma domains [7] .
Here we describe an alternative spliced form of the hTAP3/hSEC14L4 gene and a polymorphism in its coding sequence. The possible role for these hTAP3 variants is discussed.
Materials and methods
As previously described, the tissue samples were from transplant donors and had the quality of transplantable material [18] . They were immediately frozen in liquid nitrogen and kept at -80°C if not immediately processed. Total RNA was isolated from tissues using RNAeasy extraction kit (Qiagen). Reverse transcription RT-PCR was performed basically according to the RT-PCR kit from Perkin-Elmer. For detecting the alternatively spliced version of hTAP3 cDNA, a PCR product was obtained by using primers: sense TAP3-Bf ( 
Results and discussion
During sequencing of the hTAP3 (or hSEC14L4) cDNA [1] , two mutations were detected: the insertion of a short 16 bp fragment at position ?55 (Fig. 1a) , and a silent point mutation at position ?409 of the coding sequence (Fig. 1b) . Both changes are leading to the formation of new and unique restriction sites; the 16 bp insertion contained a unique BamHI restriction site, whereas the silent point mutation generated a unique PstI restriction site. This allowed the application of a fast screening method consisting of PCR-mediated amplification of a short region of the hTAP3 cDNA, followed by restriction fragment length analysis (see methods).
Because hTAP3 is not expressed in cell lines [7] , total RNA isolated from human tissues was used to screen for the presence of the hTAP3 gene variants. The analysis performed on different tissues from seven different donors indicated that the majority of the samples express about equal amounts of hTAP3 with and without the 16 bp insertion derived from alternative splicing ( Fig. 2 ; Table 1 ). At this time, no firm statement can be made about relative expression levels of the two alternatively spliced forms, since cells in a tissue could either express both forms in each cell, or one cell type in a tissue may express one form and another cell type the other. However, donor 1 contains only the correctly spliced version of hTAP3 in both liver and skin, possibly indicating that alternative (A) hTAP3 cDNA sequence +1 -+ 138 are indicated in bold. The sequence of the PCR fragment containing the alternatively spliced hTAP3 mRNA has been submitted to Genbank (accession number FJ824055). b Mutation in one base at position ?414 (A ? G, bold) (or as reverse complement, C ? T) generates a new restriction site (PstI, underlined) which is present also in the hTAP2 cDNA. Mutation itself does not change the amino acid (Gly ? Gly), but might be linked with other mutations. This mutation corresponds to the C/T small nucleotide polymorphism (dbSNP:9606738), which is described at http://www.ncbi.nlm.nih. gov/SNP/snp_ref.cgi?type=rs&rs=9606738 splicing occurs in a regulated manner, or as a consequence of additional changes that influence it in a tissue and/or individual specific manner. This may be the result of alterations in the splicing consensus sequence or the splicing machinery, although no polymorphisms have been so far described within intron 1 (http://www.ncbi.nlm.nih. gov/SNP/snp_ref.cgi?locusId=284904). Sequence analysis of the exon-intron junction between exon 1 and 2 revealed that the additional 16 bp in the alternatively spliced hTAP3 cDNA come from alternative usage of the 3 0 -splicing junction of intron 1 (Fig. 3a) . Alignment of the three closely related hTAP sequences (hTAP1, hTAP2, hTAP3) showed that the 3 0 -splice junction of hTAP3 in intron 1 is shifted by 4 nucleotides possibly allowing the usage of two alternative splicing sites (Fig. 3b) . Interspecies sequence alignment of the intron 1-exon 2 junction of hTAP3 revealed that the alternative 3 0 -splice junction is present in humans, chimpanzee, and rhesus monkeys, but not in mouse or rabbits, possibly indicating that alternative splicing of hTAP3 evolved only in higher primates (Fig. 3c) .
ATGAGCAGCCGAGTCGGGGACCTGAGCCCCCAGCAGCAGGAAGCGCTGGCCAGG----------------
The hTAP3 cDNAs from three of four tested donors contain a PstI restriction site ( Table 1 ). The PstI polymorphism (dbSNP:9606738) has been described to occur at different frequency in different ethnic groups (Table 2) (http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?type=rs& rs=9606738). In the sequences so far analyzed, the C/C genotype (PstI site present in both alleles) occurs mainly in the European, the C/T genotype (PstI site present in one allele) in the European and African, and the T/T genotype (PstI site absent in both alleles) in the Asian population.
At this time it is not possible to estimate the importance of the here described hTAP3 gene variants, because until now research has mainly focused on hTAP1 and establishing a link with certain diseases requires a better understanding of the three closely related hTAP proteins. The three hTAP proteins may participate in intracellular lipid transport and consequently influence lipid metabolism as well as lipid-dependent events, including signal transduction, gene expression and secretion.
We and others have found that hTAP proteins can modulate phosphatidylinositol-3-kinase (PI3K) in vitro [1, 16] ; other enzymes such as phosphatidylinositol-4-kinase (PI4K), phospholipases, squalene epoxidase, fatty acid synthase, and choline-phosphate cytidyltransferases may be modulated by hTAPs as well. A role for TAP proteins in the biosynthesis of cholesterol was firstly suggested by the identification of TAP1/SEC14L2 as the previously described microsomal supernatant protein factor (SPF) [19] . SPF/ TAP1/SEC14L2 stimulates squalene epoxidation, a reaction required for cholesterol synthesis, either by directly stimulating squalene transport to the enzyme or possibly by increasing the transport and generation of vesicles carrying squalene [19, 20] . As shown with TAP1/SPF-knockout mice, SPF/TAP1/SEC14L2 maintains the steady-state plasma cholesterol level during fasting by compensating for decreased squalene epoxidase and HMG-CoA reductase activity [21] .
Modulation of PI3K by hTAPs may also affect gene expression in a tocopherol-dependent manner, e.g. by affecting the PI3K/PKB/PPARc signal transduction pathway. Indeed, the involvement of TAP1 in the modulation of gene expression has been recently described; mouse TAP1 was found to stimulate the expression of the mast cell proteases genes mmcp-1 and mmcp-7, whereas the expression of TAP1 itself can be up-regulated by activin/ TGF-b treatment during differentiation of bone-marrow derived mast cells [22, 23] . The expression of hTAP1 is upregulated during primary mast cell differentiation, indicating a role of this protein in cells of the native immune system [7] . Expression of TAP2 is inversely correlated with allergic airway inflammation [24] . hTAP1 and hTAP2 are expressed, although at a low level, in several cell lines, whereas hTAP3 expression is undetectable in so far all tested cell lines; interestingly, in primary cells and tissues the three hTAP proteins appear to be more abundant [7] . These results suggest that the hTAP proteins may be expressed in the fully differentiated state or interfere with proliferation, possibly becoming downregulated during cell line expansion and/or tumor promotion [16, 25] . Accordingly, previous results suggested that (A) hTAP3 genomic sequence exon 1, intron 1 and part of exon 2 0 -splice junctions are shown in bold, the nucleotides conserved in two of the three genes in grey shading, the most likely splicing branch point adenine in hTAP1 is marked by an arrow. Homologies to the human branch point consensus sequence yTnAy are shown in bold [34] . In hTAP3, the distance of the 3 0 -splice junction to the branch point is longer, possibly explaining the usage of an additional 3 0 -splice junction in hTAP3. Intron (lower case), exon (upper case). c Alignment of the intron 1-exon 2 junctions of TAP3 from Homo sapiens (hTAP3), Macaca mulatta (mmTAP3), Pan troglodytes (ptTAP3), Mus musculus (mTAP3) and Rattus norvegicus (rTAP3). Homologies to the human branch point consensus sequence yTnAy are shown in bold [34] . The most likely branch point and alternative splicing junction are conserved in primates, but not in rodents epigenetic changes are at the basis of hTAP1 gene silencing in cancer cells, since treatment with demethylating agents can recover TAP expression [7, 16] . Moreover, overexpression of hTAP1 in mesothelioma cells renders them more sensitive to a-tocopheryl succinate, again suggesting that hTAP down-regulation may serve to escape the apoptotic effects of this anti-proliferative compound [26] . In line with this, proliferation of prostate cancer cells correlates with a reduced expression of hTAP1 [16, 17] whereas certain small nucleotide polymorphisms (SNP) in the hTAP1 gene are associated with an increased risk for prostate cancer [27, 28] . Moreover, lower levels of hTAP1 have been detected in breast cancer [25, 29] .
hTAP3/SEC14L4 is predominantly expressed in epithelial duct cells of several glands (e.g. salivary gland, prostate, pancreas, mammary gland), suggesting that it may be involved in polarized secretion from these cells [7] . Accordingly, the related Saccharomyes cerevisiae SEC14p mediates vesicle formation and secretion from endosomes and trans-Golgi network possibly through activation of PI4K [30] [31] [32] . Alternatively, the hTAP function may have shifted from lipid transfer to enzymes to lipid insertion into secretory vesicles, organelles or specific plasma domains.
In conclusion, the here detected gene polymorphism could be used as a chromosomal linkage marker, e.g. to establish a correlation between ethnic differences seen in incidences of diseases and specific hTAP3 gene variants. The presence of the alternatively spliced form could lead to reduced levels of functional hTAP3 protein expression what may not necessarily lead to a disease, but may play a role in determining inter-individual differences in the secretory and/or proliferative capability of epithelial duct cells [7] , alter the risk for certain diseases and possibly influence the disease-preventive effects of vitamin E in supplementation studies [33] .
A further analysis of the biological relevance of the here described hTAP3 variants requires the definite assignment of the wild type hTAP3 function. Future studies should address the molecular role of these hTAP3 variants and their pattern of expression in normal and pathological tissues, possibly with single cell resolution to reveal cell type specific splicing patterns.
